Edition:
United States

People: Eli Lilly and Co (LLY.N)

LLY.N on New York Stock Exchange

81.59USD
22 Jul 2016
Change (% chg)

$1.19 (+1.48%)
Prev Close
$80.40
Open
$80.40
Day's High
$81.71
Day's Low
$80.30
Volume
1,271,386
Avg. Vol
1,298,249
52-wk High
$92.83
52-wk Low
$67.88

Lechleiter, John 

Dr. John C. Lechleiter, Ph.D., is Chairman of the Board, President, Chief Executive Officer of Eli Lilly And Co. He is our chairman, president, and chief executive officer. A Ph.D. chemist by training, Dr. Lechleiter has over 36 years of experience with the company in a variety of roles of increasing responsibility in research and development, pharmaceutical operations, and corporate administration. As a result, he has a sound understanding of pharmaceutical research and development, sales and marketing, and manufacturing. He also has significant corporate governance experience through his service on other public company boards.

Basic Compensation

Total Annual Compensation, USD 5,122,500
Restricted Stock Awards, USD 11,350,000
Long-Term Incentive Plans, USD --
All Other, USD 90,000
Fiscal Year Total, USD 16,562,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 140,964 2,864,830.00
Name Fiscal Year Total

John Lechleiter

16,562,500

Derica Rice

6,935,410

Maria Crowe

--

Jan Lundberg

6,778,350

Melissa Barnes

--

Michael Harrington

4,780,500
As Of  30 Dec 2015